Introduction {#s1}
============

Men who have sex with men (MSM) have become one of main subgroup populations at high risk of HIV infection in China in the past decade [@pone.0072747-Ministry1]. Chinese MSM tend to live in large- or middle-size cities rather than in small towns and rural areas for numerous considerations, e.g., there are more job opportunities; it is easier to find sexual partners; there are more socially tolerant environments which also keep some MSM away from their family members and acquaintances in their hometowns. MSM have lived in situations of repression, negative feedback, and discrimination and stigma. They often are poorly informed as to their sexual risks; a desire for intimacy and sexual fulfillment tends to outweigh the possible consequences of unprotected sex and the risks associated with it. Risky behaviors can occur in the context of an increasing number of MSM with HIV infection, some in acute stages of infection with very high HIV viral loads. The twin-epidemic of HIV and of STI can increase HIV viral expression and break down the integrity of mucosal surfaces and can further recruit HIV target cells to the infected area. HIV has spread quickly among Chinese MSM particularly in urban areas [@pone.0072747-Chow1], [@pone.0072747-Chow2], [@pone.0072747-Meng1]; a national survey in 61 cities in years 2008 and 2009 showed 4.9% prevalence rate [@pone.0072747-Wu1]. It is an urgent need to find effective intervention approaches to respond to the emerging epidemic among MSM in China as well as in other areas of the world [@pone.0072747-Beyrer1].

Attitudes towards sex and sexual behaviors in China have evolved over thousands of years, but have advanced rapidly in recent years, reflecting cultural input consequent to industrialization and Western cultural norms and values in the past 30 years. Now people in China tend to be more tolerant towards homosexuality which has begun to be considered as a legitimate lifestyle choice. Although Chinese government has prioritized HIV prevention programs for MSM population, these programs often do not involve gay community and their community based organizations (CBOs), and therefore, their impact may be limited [@pone.0072747-Ye1]. Unprotected sex and frequent change of sexual partners are prevalent among Chinese MSM, particularly among young MSM [@pone.0072747-Yu1], and abuse of alcohol and club drugs further increase unprotected sex in a group of MSM [@pone.0072747-Gerbi1], [@pone.0072747-Shuper1], [@pone.0072747-Gerbi2] and put MSM at higher risk of contracting and transmitting HIV.

Two recently published meta-analyses evaluated the efficacy of HIV prevention intervention among MSM in China, suggesting that interventions may increase condom use, uptake of HIV testing, and HIV-related knowledge [@pone.0072747-Huang1], [@pone.0072747-Zheng1]. There were numerous more recent intervention studies evaluating the efficacy on HIV-related behaviors, attitudes, and knowledge in China [@pone.0072747-Hao1], [@pone.0072747-Tan1], [@pone.0072747-Wang1], [@pone.0072747-Duan1], [@pone.0072747-Guo1]. Hence, we conducted an updated systematic review and meta-analysis to evaluate the effects of HIV risk reduction interventions on knowledge, attitudes, behaviors and disease prevalence among Chinese MSM.

Results {#s2}
=======

Results from Literature Search {#s2a}
------------------------------

Our search yielded 1896 entries from twelve electronic databases ([Figure 1](#pone-0072747-g001){ref-type="fig"}); 864 titles and abstracts were reviewed and 1032 duplicates were removed. We excluded 814 citations because they did not meet one or more of the inclusion criteria. Out of 50 potential relevant papers for full text reviewing, 16 were further excluded because of not original article (i.e., editorial, comment, or review; k = 8), no specific intervention involved (k = 4), lack of information on target outcomes (k = 3), and repeated report from the same study (k = 1). The excluded articles are listed in [Appendix S1](#pone.0072747.s001){ref-type="supplementary-material"}. We included 34 studies in our systematic review.

![Flow diagram of the literature search process^1^.\
^1^ Twelve databases included: 1) AMED; 2) BNI; 3) EMBASE; 4) CNKI; 5) CQVIP; 6) EconLit; 7) ERIC; 8) Medline; 9) PsycINFO; 10) Scopus; 11) ISI Web of Science; 12) Wanfang Data.](pone.0072747.g001){#pone-0072747-g001}

Of 34 studies, study design included: two RCT [@pone.0072747-Hao1], [@pone.0072747-Lau1], six quasi-experimental studies [@pone.0072747-Tan1], [@pone.0072747-Duan1], [@pone.0072747-Gao1], [@pone.0072747-Wang2], [@pone.0072747-Gao2], [@pone.0072747-Zhang1], six self-pre-and-post intervention studies without control groups [@pone.0072747-Guo1], [@pone.0072747-Song1], [@pone.0072747-Zhu1], [@pone.0072747-He1], [@pone.0072747-Meng2], [@pone.0072747-Wang3], and twenty serial cross-sectional studies ([Table 1](#pone-0072747-t001){ref-type="table"}). A large variation of rigor scores was noted, ranging from 0 to 8, with a mean score of 2.5. One study had a rigor score of zero [@pone.0072747-Xu1], nineteen had a score of one, and only five had a score of ≥6 [@pone.0072747-Hao1], [@pone.0072747-Lau1], [@pone.0072747-Gao1], [@pone.0072747-Gao2], [@pone.0072747-Zhang1] ([Table 2](#pone-0072747-t002){ref-type="table"}).

10.1371/journal.pone.0072747.t001

###### Characteristics of HIV intervention prevention studies among Chinese men who have sex with men.

![](pone.0072747.t001){#pone-0072747-t001-1}

  Publication                                         City (trial period)           Study participants      Description of interventions            Study design                                         Follow-up (months)                                              Drop-out (%)                          
  ------------------------------------------- ------------------------------------ -------------------- ------------------------------------- ------------------------ -------------------------------------------------------------------------------------- ----------------------------------- ------ ----- -----
  Gao et al. [@pone.0072747-Gao1], 2005                  Chengdu (N/A)                   EBS, RDS        135→135^A^ 140→140^B^ (N/A, 16--46)   145→145 (N/A, 16--46)    A: self-facilitate peer-led intervention; B: social-facilitate peer-led intervention              No specific              QES     5     0
  Song et al. [@pone.0072747-Song1], 2005                Shenzhen (N/A)                    EBS                   109→71 (24, 16--46)                    N/A                                            Multi-way intervention                                                 N/A                  SPIS    0    35
  Wang et al. [@pone.0072747-Wang2], 2005                Chengdu (N/A)                     RDS                  20→150 (N/A, 16--42)           150→150 (N/A, 16--42)                                   Multi-way intervention                                             No specific              QES     5    14
  Xu et al. [@pone.0072747-Xu1], 2006               Chengdu & Kunming (2005)               EBS                   48→48 (32, 18--69)                     N/A                                            Multi-way intervention                                                 N/A                  SCIS   60    N/A
  Gao et al. [@pone.0072747-Gao2], 2007                  Chengdu (N/A)                   EBS, RDS                80→80 (25, 17--50)              80→80 (25, 17--50)                                    Peer-led intervention                                             No described              QES     5     0
  Lau et al. [@pone.0072747-Lau1], 2008                 Hong Kong (N/A)                  EBS, WDS              238→140 (N/A, 18--41+)          239→140 (N/A, 18--41+)                               Internet-based intervention                                Educational materials distributed   RCT     6    41
  Liu et al. [@pone.0072747-Liu1], 2008              Chongqing (2006--2007)                EBS                    180→207 (23, N/A)                     N/A                                            Multi-way intervention                                                 N/A                  SCIS   12    N/A
  Wang et al. [@pone.0072747-Wang4], 2008            Mianyang (2006--2007)                 RDS                  201→200 (24, 16--57)                    N/A                                            Peer-led intervention                                                  N/A                  SCIS    6    N/A
  Zhu et al. [@pone.0072747-Zhu1], 2008            Hefei, Wuhu & Fuyang (N/A)              PDR                  218→170 (24, 18--61)                    N/A                                            Peer-led intervention                                                  N/A                  SPIS    3    22
  Cao et al. [@pone.0072747-Cao1], 2009        Shenyang, Chengdu & Nanjing (2007)          EBS                  484→553 (21, 16--45)                    N/A                                            Multi-way intervention                                                 N/A                  SCIS    6    N/A
  Feng et al. [@pone.0072747-Feng1], 2009            Chongqing (2006--2007)                RDS                   1000→772 (28, ≥18)                     N/A                                            Multi-way intervention                                                 N/A                  SCIS   12    N/A
  Wang M et al. [@pone.0072747-Wang5], 2009               Wuhan (2006)                     SBS                  222→224 (N/A, 15--24)                   N/A                                            Multi-way intervention                                                 N/A                  SCIS    6    N/A
  Wang Y et al. [@pone.0072747-Wang6], 2009          Mianyang (2006--2008)                 RDS                201→200→203 (24, 16--57)                  N/A                                            Peer-led intervention                                                  N/A                  SCIS   24    N/A
  Xiu et al. [@pone.0072747-Xiu1], 2009               Qingdao (2007--2008)                 EBS                  216→199 (27, 18--50)                    N/A                                            Multi-way intervention                                                 N/A                  SCIS   N/A   N/A
  Xu et al. [@pone.0072747-Xu2], 2009                  Wuhan (2007--2008)                  EBS                  253→154 (27, 15--61)                    N/A                                            Multi-way intervention                                                 N/A                  SCIS    6    N/A
  Zeng et al. [@pone.0072747-Zeng1], 2009            18 cities (2006--2008)              RDS, WDS                5178→5460 (26, ≥18)                    N/A                                            Multi-way intervention                                                 N/A                  SCIS   24    N/A
  Zhang et al. [@pone.0072747-Zhang1], 2009         Mianyang & Yibin (2007)                PDS                 200→200 (N/A, 18--35+)          200→200 (N/A, 18--35+)                                  Peer-led intervention                                       Routine HIV intervention        QES     6     0
  Ding et al. [@pone.0072747-Ding1], 2010            Chongqing (2006--2008)                SBS               1000→1044→743 (27, 18--68)                 N/A                                            Multi-way intervention                                                 N/A                  SCIS   24    N/A
  He et al. [@pone.0072747-He1], 2010                  Wuhu (2006--2008)                   RDS                  360→306 (23, 15--48)                    N/A                                            Multi-way intervention                                                 N/A                  SPIS   24    15
  Ma et al. [@pone.0072747-Ma1], 2010                 Xiamen (2008--2009)                  RDS                  98→140→154 (25, N/A)                    N/A                                            Multi-way intervention                                                 N/A                  SCIS   14    N/A
  Meng et al. [@pone.0072747-Meng2], 2010                 Pulan (2009)                     SBS                   62→62 (28, 19--49)                     N/A                                            Peer-led intervention                                                  N/A                  SPIS   10     0
  Nong et al. [@pone.0072747-Nong1], 2010             Nanning (2007--2008)                 EBS                  230→452→452 (25, N/A)                   N/A                                            Multi-way intervention                                                 N/A                  SCIS   12    N/A
  Zhang et al. [@pone.0072747-Zhang2], 2010           Guilin (2008--2009)                  EBS                  315→346 (28, 18--51+)                   N/A                                            Multi-way intervention                                                 N/A                  SCIS   12    N/A
  Li et al. [@pone.0072747-Li1], 2011                 Nanjing (2008--2010)                 SBS                  606→616→400 (28, ≥18)                   N/A                                            Multi-way intervention                                                 N/A                  SCIS   24    N/A
  Qu et al. [@pone.0072747-Qu1], 2011             Hohhot & Baotou (2008--2009)             SBS                  706→767 (27, 18--63)                    N/A                                            Peer-led intervention                                                  N/A                  SCIS   12    N/A
  Wang F et al. [@pone.0072747-Wang7], 2011           Yingtan (2009--2010)                 PDS                    135→134 (27, N/A)                     N/A                                            Multi-way intervention                                                 N/A                  SCIS   12    N/A
  Wang L et al. [@pone.0072747-Wang8], 2011             N/A (2008--2010)                   SBS                    500→496 (23, ≥18)                     N/A                                           HIV testing intervention                                                N/A                  SCIS   24    N/A
  Wang Y et al. [@pone.0072747-Wang3], 2011          Nanchang (2006--2007)                 EBS                   101→101 (N/A, N/A)                     N/A                                            Peer-led intervention                                                  N/A                  SPIS   12     0
  Wu et al. [@pone.0072747-Wu2], 2011                  Wuhu (2009--2010)                   SBS                  244→179 (20, 18--25)                    N/A                                            Multi-way intervention                                                 N/A                  SCIS    6    N/A
  Hao et al. [@pone.0072747-Hao1], 2012               Nanjing (2008--2009)                 RDS                  149→100 (28, 18--73)            146→111 (28, 18--73)                               Enhanced voluntary counseling                                 Standard voluntary counseling     RCT     6    28
  Tan et al. [@pone.0072747-Tan1], 2012              Shenzhen (2009--2010)                 EBS                    111→120 (28, N/A)               105→98 (26, N/A)                                        IEC intervention                                     Educational materials distributed   QES    12    N/A
  Wang et al. [@pone.0072747-Wang1], 2012             Harbin (2006--2010)                  SBS            400→419→451→450→413 (N/A, 18--79)             N/A                                            Multi-way intervention                                                 N/A                  SCIS   48    N/A
  Duan et al. [@pone.0072747-Duan1], 2013        Mianyang & Yibin (2006--2008)             PDS                   200→200 (N/A, ≥18)              200→200 (N/A, ≥18)                                    Peer-led intervention                                       Routine HIV intervention        QES    12    N/A
  Guo et al. [@pone.0072747-Guo1], 2013                 Langfang (2007)               WDS, PDS, EBS              233→200 (N/A, ≥18)                     N/A                                           HIV testing intervention                                                N/A                  SPIS    3    14

**NOTE:** EBS: establishment-based sampling; RDS: respondent-driven sampling; PDS: peer-driven sampling; WDS: web-driven sampling; SBS: snowball sampling; IEC: information, education, communication; QES: quasi-experimental study, SCIS: serial cross-sectional intervention studies; SPIS: self-pre-and-post intervention studies without comparison group; RCT: randomized control trial; N/A: Not available.

10.1371/journal.pone.0072747.t002

###### Quality assessment of study design (rigor score[\*](#nt102){ref-type="table-fn"}).

![](pone.0072747.t002){#pone-0072747-t002-2}

  Publication                                  Cohort (a)   With control group (b)   Pre/post intervention (c)   Random assignment (d)   Random selection for assessment (e)   Sample size \>100 (f)   Follow-up≥80% (g)   Comparable socio-demographics between study arms (h)   Comparable outcome measures at baseline (i)   Total
  ------------------------------------------- ------------ ------------------------ --------------------------- ----------------------- ------------------------------------- ----------------------- ------------------- ------------------------------------------------------ --------------------------------------------- -------
  Gao et al. [@pone.0072747-Gao1], 2005            1                  1                          1                         0                              0                              1                     1                                   0.5                                                 1                         6.5
  Song et al. [@pone.0072747-Song1], 2005          1                  0                          1                         0                              0                              1                     0                                    0                                                  0                          3
  Wang et al. [@pone.0072747-Wang2], 2005          1                  1                          1                         0                              0                              1                     1                                   0.5                                                 0                         5.5
  Xu et al. [@pone.0072747-Xu1], 2006              0                  0                          0                         0                              0                              0                     0                                    0                                                  0                          0
  Gao et al. [@pone.0072747-Gao2], 2007            1                  1                          1                         0                              0                              1                     1                                    1                                                  1                          7
  Lau et al. [@pone.0072747-Lau1], 2008            1                  1                          1                         1                              1                              1                     0                                    1                                                  1                          8
  Liu et al. [@pone.0072747-Liu1], 2008            0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Wang et al. [@pone.0072747-Wang4], 2008          0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Zhu et al. [@pone.0072747-Zhu1], 2008            1                  0                          1                         0                              0                              1                     0                                    0                                                  0                          3
  Cao et al. [@pone.0072747-Cao1], 2009            0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Feng et al. [@pone.0072747-Feng1], 2009          0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Wang M et al. [@pone.0072747-Wang5], 2009        0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Wang Y et al. [@pone.0072747-Wang6], 2009        0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Xiu et al. [@pone.0072747-Xiu1], 2009            0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Xu et al. [@pone.0072747-Xu2], 2009              0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Zeng et al. [@pone.0072747-Zeng1], 2009          0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Zhang et al. [@pone.0072747-Zhang1], 2009        1                  1                          1                         0                              0                              1                     1                                    0                                                  1                          6
  Ding et al. [@pone.0072747-Ding1], 2010          0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  He et al. [@pone.0072747-He1], 2010              1                  0                          1                         0                              0                              1                     0                                    0                                                  0                          3
  Ma et al. [@pone.0072747-Ma1], 2010              0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Meng et al. [@pone.0072747-Meng2], 2010          1                  0                          1                         0                              0                              0                     1                                    0                                                  0                          3
  Nong et al. [@pone.0072747-Nong1], 2010          0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Zhang et al. [@pone.0072747-Zhang2], 2010        0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Li et al. [@pone.0072747-Li1], 2011              0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Qu et al. [@pone.0072747-Qu1], 2011              0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Wang F et al. [@pone.0072747-Wang7], 2011        0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Wang L et al. [@pone.0072747-Wang8], 2011        0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Wang Y et al. [@pone.0072747-Wang3], 2011        1                  0                          1                         0                              0                              1                     1                                    0                                                  0                          4
  Wu et al. [@pone.0072747-Wu2], 2011              0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Hao et al. [@pone.0072747-Hao1], 2012            1                  1                          1                         1                              1                              1                     0                                    1                                                  1                          8
  Tan et al. [@pone.0072747-Tan1], 2012            0                  1                          0                         0                              0                              1                     0                                    1                                                  1                          4
  Wang et al. [@pone.0072747-Wang1], 2012          0                  0                          0                         0                              0                              1                     0                                    0                                                  0                          1
  Duan et al. [@pone.0072747-Duan1], 2013          0                  1                          0                         0                              0                              1                     0                                    0                                                  0                          2
  Guo et al. [@pone.0072747-Guo1], 2013            1                  0                          1                         0                              0                              1                     1                                    0                                                  0                          4

One point score for meeting each of the following items (if data were not available in the articles for any item, 0.5 was recorded):

was a prospective cohort,

used a comparison arm,

collected pre and post intervention data,

used random assignment of participants to study arms,

did random sampling for assessments,

sample size \>100,

follow-up rate ≥80%,

had a comparison group with comparable socio-demographics such as age, education, race, employment, income, marital status and others \[score "1" if \>50% variables were comparable between study arms, and '0' if not\], and

had a comparison arm with comparable outcome measures at baseline between study arms.

Consistent Condom Use {#s2b}
---------------------

A variety of condom use outcomes were reported, e.g., in anal sex with regular, casual, and/or mixed sexual partners and were measured during various recall periods, e.g., during last sexual encounter, in the past month, and/or the past six months ([Table 3](#pone-0072747-t003){ref-type="table"}). The overall effectiveness of risk reduction interventions on consistent condom use with any sexual partners during anal intercourse is presented in [Figure 2](#pone-0072747-g002){ref-type="fig"}. Twenty five studies reported a positive association between interventions and consistent condom use, and 17 had statistical significance. Meta-analysis of these 25 studies showed that risk reduction intervention increased consistent condom use (mean ES: 0.46; 95% CI: 0.35, 0.56; *P*\<0.01). Large heterogeneity was observed among these studies (I^2^ = 87.2%; *P*\<0.01). The funnel plot show significant evidence of publication bias (Kendall tau = 0.31; *P* = 0.03; Egger's t value = 3.86; *P*\<0.01).

![Forest plot of effect size: the impact of behavioral interventions on consistent condom use during anal intercourses with any male sexual partners among MSM in China.](pone.0072747.g002){#pone-0072747-g002}

10.1371/journal.pone.0072747.t003

###### Behavioral, biomedical, and knowledge outcomes of HIV intervention studies among Chinese MSM.

![](pone.0072747.t003){#pone-0072747-t003-3}

  Publication                                                                                                                                       Consistent condom use (%)                                                                                                                 Uptake of HIV testing (%)                                          HIV/AIDS-related knowledge and attitudes (%)   HIV/STI prevalence (%)                                                                                                                                                                                                          
  ------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- ---------------------------------------------- ------------------------ ----------------------------------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------ ------------------
  Gao et al. [@pone.0072747-Gao1], 2005[\*](#nt113){ref-type="table-fn"}                                                       AI with CP^PM6^ 4.6→66.6 3.7→51.1 AI with RP^PM6^ 4.1→46.8 4.1→26.5                                                                                 AI with CP^PM6^ 3.8→4.5 AI with RP^PM6^ 3.4→4.2                                                   N/A                                 N/A                  Knowledge 11.1→76.3 10.7→58.6 Attitude 16.3→67.4 14.2→61.4                      Knowledge 11.0→11.7 Attitude 15.1→16.5                                           N/A                                     N/A
  Song et al. [@pone.0072747-Song1], 2005                                                                                                               AI^PM6^ 11.9→63.0                                                                                                                                N/A                                                                         N/A                                 N/A                                      Knowledge 60.7→84.2                                                          N/A                                                             N/A                                     N/A
  Wang et al. [@pone.0072747-Wang2], 2005                                                                                                   AI with RP 10.5→35.5 AI with CP 6.5→49.7                                                                                                    AI with RP 6.8→6.2 AI with CP 3.1→5.3                                                        N/A                                 N/A                            Knowledge 31.0→71.8 Attitude 34.1→68.5                                Knowledge 32.3→32.5 Attitude 32.4→31.2                                           N/A                                     N/A
  Xu et al. [@pone.0072747-Xu1], 2006                                                                                                                   AI^PM1^18.8→58.3                                                                                                                                 N/A                                                                         N/A                                 N/A                                      Knowledge 16.7→90.8                                                          N/A                                                             N/A                                     N/A
  Gao et al. [@pone.0072747-Gao2], 2007                                                                                                      AI with CP 4.3→76.8 AI with RP 3.1→46.2                                                                                                    AI with CP 2.9→4.2 AI with RP 3.2→4.8                                                        N/A                                 N/A                            Knowledge 11.3→86.3 Attitude 16.3→87.5                                Knowledge 10.8→11.2 Attitude 15.0→16.2                                           N/A                                     N/A
  Lau et al. [@pone.0072747-Lau1], 2008                                                                                                AI with CP^PM6^ 63.0→60.0 AI with RP^PM6^ 37.3→42.9                                                                                       AI with CP^PM6^ 49.1→61.1 AI with RP^PM6^ 30.8→39.3                                          VCT^PM6^ 20.7→15.7                  VCT^PM6^ 10.7→12.1                              Knowledge 88.6→93.6                                                  Knowledge 87.9→94.3                                               STD^PM6^ 5.7→2.9                        STD^PM6^ 2.1→4.3
  Liu et al. [@pone.0072747-Liu1], 2008                                                                                                        AI^PM6^ 40.9→50.2 AI^PM0^ 64.3→75.8                                                                                                                       N/A                                                                      18.3→58.0                              N/A                                      Knowledge 35.6→65.2                                                          N/A                                                             N/A                                     N/A
  Wang et al. [@pone.0072747-Wang4], 2008                                                                                                               AI^PM6^ 31.5→52.0                                                                                                                                N/A                                                                      26.9→45.5                              N/A                                      Knowledge 68.6→76.6                                                          N/A                                                             N/A                                     N/A
  Zhu et al. [@pone.0072747-Zhu1], 2008                                                                                       AI^PM0^ 56.4→65.2 AI with CP^PM0^ 46.2→52.5 AI with RP^PM0^ 48.4→60.9                                                                                                      N/A                                                                         N/A                                 N/A             Knowledge[\*\*](#nt114){ref-type="table-fn"} 14.71(2.59) →16.95(1.81)                                 N/A                                                             N/A                                     N/A
  Cao et al. [@pone.0072747-Cao1], 2009                                                                                                       IAI^PM3^ 71.7→83.7 IAI^PM0^ 86.5→90.4                                                                                                                      N/A                                                                      69.6→70.5                              N/A                                      Knowledge 62.7→91.9                                                          N/A                                                             N/A                                     N/A
  Feng et al. [@pone.0072747-Feng1], 2009                                                                                                        AI^PM0&PM6^ 56.4→65.5 31.8→41.9                                                                                                                         N/A                                                                         N/A                                 N/A                                      Knowledge 74.3→82.4                                                          N/A                                                Syphilis 9.3→7.3 HIV 10.4→10.8                       N/A
  Wang M et al. [@pone.0072747-Wang5], 2009                                                                                            AI with CP^PM1^ 25.2→25.6 AI with RP^PM1^ 15.3→23.4                                                                                                               N/A                                                                         N/A                                 N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A
  Wang Y et al. [@pone.0072747-Wang6], 2009                                 AI^PM6^ 31.5→41.3→52.9 AI with CP^PM6^ 30.3→47.1→57.8 AI with RP^PM6^ 23.7→38.7→43.0 AI^PM0^ 54.0→73.1→82.8 AI with CP^PM0^ 65.2→74.2→88.9 AI with RP^PM0^ 51.7→71.1→82.0                                                    N/A                                                                         N/A                                 N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A
  Xiu et al. [@pone.0072747-Xiu1], 2009                                                                                                                 AI^PM6^ 45.3→63.8                                                                                                                                N/A                                                                         N/A                                 N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A
  Xu et al. [@pone.0072747-Xu2], 2009                                                                        AI with CP^PM6^ 40.3→39.0 AI with CP^PM0^ 50.2→70.6 AI with RP^PM6^ 38.3→48.7 AI with RP^PM0^ 37.7→56.6                                                                                     N/A                                                                      37.9→36.4                              N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A
  Zeng et al. [@pone.0072747-Zeng1], 2009                                                                                                        AI^PM0&PM6^ 58.0→76.7 28.2→44.5                                                                                                                         N/A                                                                      18.8→39.1                              N/A                                      Knowledge 76.0→90.5                                                          N/A                                                         HIV 2.3→5.0                                 N/A
  Zhang et al. [@pone.0072747-Zhang1], 2009                                                                                            AI with CP^PM0^ 80.5→89.0 AI with RP^PM0^ 67.0→72.0                                                                                       AI with CP^PM0^ 82.5→81.0 AI with RP^PM0^ 70.5→75.0                                               9.0→22.0                           24.5→24.0                                           N/A                                                                  N/A                                                             N/A                                     N/A
  Ding et al. [@pone.0072747-Ding1], 2010                                                                                                 AI^PM6^ 31.8→36.2→36.7 AI^PM0^ 56.4→61.2→64.4                                                                                                                  N/A                                                                    18.9→35.2→32.0                           N/A                                   Knowledge 90.0→89.5→90.7                                                        N/A                                           HIV 10.4→12.5→17.0 Syphilis 9.3→8.5→8.5                   N/A
  He et al. [@pone.0072747-He1], 2010                                                                                                    AI 9.7→22.9^PM6^ 13.3→25.5^PM1^ 14.7→41.2^PM0^                                                                                                                  N/A                                                                         N/A                                 N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A
  Ma et al. [@pone.0072747-Ma1], 2010                                                                                                                AI^PM0^ 71.7→66.7→76.6                                                                                                                              N/A                                                                    32.7→42.1→59.1                           N/A                                   Knowledge 43.9→45.9→59.7                                                        N/A                                    HIV 2.0→1.4→2.6 Syphilis 9.2→4.3→10.4 HCV 1.0→0.7→0.7            N/A
  Meng et al. [@pone.0072747-Meng2], 2010                                                                                                      AI^PM1^ 6.45→37.1 AI^PM0^ 27.4→77.4                                                                                                                       N/A                                                                         N/A                                 N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A
  Nong et al. [@pone.0072747-Nong1], 2010                                                                                                AI^PM6^ 43.0→34.6→45. 2 AI^PM0^ 72.2→64.4→75.1                                                                                                                  N/A                                                                    28.3→38.7→44.7                           N/A                                              N/A                                                                  N/A                                         HIV 0.87→1.99→2.43 Syphilis 10.43→8.18→11.28                N/A
  Zhang et al. [@pone.0072747-Zhang2], 2010                                                                                                             AI^PM6^ 15.1→46.4                                                                                                                                N/A                                                                      17.8→55.2                              N/A                                      Knowledge 30.2→37.9                                                          N/A                                                        HIV 1.59→2.02                                N/A
  Li et al. [@pone.0072747-Li1], 2011                                                                      AI^PM6^ 41.9→56.8→50.8 AI^PM0^ 57.8→67.5→64.0 AI with CP^PM6^ 64.7→36.4→65.8 AI with RP^PM6^ 47.5→45.6→40.1                                                                                   N/A                                                                         N/A                                 N/A                                   Knowledge 97.0→97.4→98.8                                                        N/A                                            HIV 4.0→2.1→2.8 Syphilis 11.4→7.5→7.8                    N/A
  Qu et al. [@pone.0072747-Qu1], 2011                                                                                                          AI^PM6^ 38.0→45.3 AI^PM0^ 81.4→82.5                                                                                                                       N/A                                                                         N/A                                 N/A                                      Knowledge 70.7→81.7                                                          N/A                                                         HIV 1.7→1.7                                 N/A
  Wang F et al. [@pone.0072747-Wang7], 2011                                                                                                    AI^PM6^ 23.7→77.6 AI^PM0^ 49.6→89.6                                                                                                                       N/A                                                                         N/A                                 N/A                                      Knowledge 63.0→95.5                                                          N/A                                                             N/A                                     N/A
  Wang L et al. [@pone.0072747-Wang8], 2011                                                                                                    AI^PM6^ 12.5→27.5 AI^PM0^ 58.9→75.8                                                                                                                       N/A                                                                      44.4→65.2                              N/A                                      Knowledge 56.8→87.0                                                          N/A                                                         HIV 6.2→5.6                                 N/A
  Wang Y et al. [@pone.0072747-Wang3], 2011                                                                                                               AI 84.8→93.2                                                                                                                                   N/A                                                                         N/A                                 N/A                                      Knowledge 81.1→88.2                                                          N/A                                                             N/A                                     N/A
  Wu et al. [@pone.0072747-Wu2], 2011                                                                                                          AI^PM6^ 29.4→25.0 AI^PM0^ 56.5→67.9                                                                                                                       N/A                                                                         N/A                                 N/A                                      Knowledge 81.8→92.0                                                          N/A                                                             N/A                                     N/A
  Hao et al. [@pone.0072747-Hao1], 2012                                                                                       AI^PM6^28.1→51.6 AI with CP^PM6^ 48.9→63.2 AI with RP^PM6^ 22.2→47.8                                                                      AI^PM6^ 27.4→33.3 AI with CP^PM6^ 46.7→47.5 AI with RP^PM6^ 21.4→31.1                                        N/A                                 N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A
  Tan et al. [@pone.0072747-Tan1], 2012                                                                                                        AI^PM6^ 39.2→61.6 AI^PM0^ 73.0→85.0                                                                                                       AI^PM6^ 42.9→→33.3 AI^PM0^ 64.0→65.3                                                     69.4→90.8                           52.4→56.1                                   Knowledge 73.0→91.7                                                  Knowledge 66.7→68.4                                                     N/A                                     N/A
  Wang et al. [@pone.0072747-Wang1], 2012                                                                                                       AI^PM6^ 38.7→36.3→ 41.8→44.1→52.9                                                                                                                        N/A                                                              26.2→31.0→ 37.0→56.4→47.2                      N/A                                              N/A                                                                  N/A                                  HIV 1.0→2.9→ 3.5→5.1→7.5 Syphilis 9.2→15.5→ 14.4→22.4→15.7         N/A
  Duan et al. [@pone.0072747-Duan1], 2013                                                                     AI with CP^PM6^ 32.1→58.4 AI with RP^PM6^ 23.7→42.5 AI with CP^PM0^ 5.7→18.2 AI with RP^PM0^51.7→78.0                                     AI with CP^PM6^ 36.4→30.2 AI with RP^PM6^ 30.3→21.6 AI with CP^PM0^ 18.1→5.8 AI with RP^PM0^ 58.5→41.1                       N/A                                 N/A               Knowledge[\*\*](#nt114){ref-type="table-fn"} 15.1(2.3) →12.4(3.3)     Knowledge[\*\*](#nt114){ref-type="table-fn"} 9.9(3.0) →11.6(3.6)                              N/A                                     N/A
  Guo et al. [@pone.0072747-Guo1], 2013                                                                                                                 AI^PM3^50.7→51.5                                                                                                                                 N/A                                                                         N/A                                 N/A                                              N/A                                                                  N/A                                                             N/A                                     N/A

**NOTE:** MSM: men who have sex with men; IG: intervention group; CG: comparison group; AI: anal intercourse; CP: casual partners; RP: regular partners; VCT: voluntary counseling and testing;

Gao et al. [@pone.0072747-Gao1], 2005 conducted 2 independent intervention patterns with the same control group, including self-facilitate peer-led intervention and social-facilitate peer-led intervention;

Knowledge scores as score mean (standard deviance).

The effectiveness was also shown in subgroup analyses by: (1) type of sexual partners (2) recall period, (3) number of study sites, (4) venue of recruiting participants, (5) type of risk reduction intervention, (6) study design, (7) sample size at baseline, and (8) rigor score ([Table 4](#pone-0072747-t004){ref-type="table"}). In standardized deleted residual analysis, four studies [@pone.0072747-Song1], [@pone.0072747-Meng2], [@pone.0072747-Zhang2], [@pone.0072747-Wu2] were identified as outliers (standardized deleted residual = 3.40 [@pone.0072747-Song1], 2.02 [@pone.0072747-Meng2], 2.05 [@pone.0072747-Zhang2],−2.23 [@pone.0072747-Wu2]). Further sensitivity analyses were used to evaluate the stability of summary effect size in the meta-analysis by excluding the outlier studies. Summary effect sizes were not changed after these exclusions ([Table 4](#pone-0072747-t004){ref-type="table"}).

10.1371/journal.pone.0072747.t004

###### Subgroup and sensitivity analyses of consistent condom use with any sexual partners during anal intercourse.

![](pone.0072747.t004){#pone-0072747-t004-4}

  Subgroup                                              No. of studies (k)   Combined ES (95% CI)   *P*-value   Heterogeneity  
  ---------------------------------------------------- -------------------- ---------------------- ----------- --------------- --------
  Recall period on consistent condom use (months)                                                                              
  Last sex                                                      16            0.42 (0.28, 0.56)      \<0.01         89.6%       \<0.01
  Past 6 months                                                 19            0.48 (0.35, 0.60)      \<0.01         89.5%       \<0.01
  Number of study sites                                                                                                        
  One                                                           20            0.51 (0.34, 0.67)      \<0.01         88.8%       \<0.01
  Multiple                                                      6             0.35 (0.22, 0.48)      \<0.01         80.3%       \<0.01
  Venue of recruiting participants                                                                                             
  Establishment-based                                           10            0.59 (0.32, 0.85)      \<0.01         89.2%       \<0.01
  Other                                                         16            0.40 (0.28, 0.52)      \<0.01         86.4%        0.01
  Type of risk reduction interventions                                                                                         
  Peer-led                                                      6             0.44 (0.22, 0.67)      \<0.01         73.9%        0.01
  Multi-way                                                     20            0046 (0.33, 0.59)      \<0.01         89.1%       \<0.01
  Study design                                                                                                                 
  Randomized clinical evaluation                                1             0.44 (−0.02, 0.90)       --            --           --
  Quasi-experimental evaluation                                 1             0.95 (0.48, 1.42)        --            --           --
  Self-pre-and-post intervention evaluation                     6             0.66 (0.23, 1.09)      \<0.01         89.0%       \<0.01
  Serial cross-sectional evaluation                             18            0.40 (0.29, 0.52)      \<0.01         88.1%       \<0.01
  Sample size at baseline                                                                                                      
  ≤300                                                          17            0.55 (0.34, 0.76)      \<0.01         87.5%       \<0.01
  \>300                                                         9             0.38 (0.26, 0.50)      \<0.01         88.2%       \<0.01
  Rigor score                                                                                                                  
  1                                                             18            0.40 (0.29, 0.52)      \<0.01         88.1%       \<0.01
  \>1                                                           8             0.66 (0.32, 1.01)      \<0.01         86.1%       \<0.01
  **Sensitivity analyses**                                                                                                     
  Song et al. [@pone.0072747-Song1], 2005 excluded              25            0.42 (0.32, 0.52)      \<0.01         85.9%       \<0.01
  Meng et al. [@pone.0072747-Meng2], 2010 excluded              25            0.44 (0.33, 0.55)      \<0.01         87.3%       \<0.01
  Zhang et al. [@pone.0072747-Zhang2], 2010 excluded            25            0.43 (0.32, 0.53)      \<0.01         85.8%       \<0.01
  Wu et al. [@pone.0072747-Wu2], 2011 excluded                  25            0.48 (0.37, 0.58)      \<0.01         86.7%       \<0.01

**NOTE:** ES: effect size; CI: confidence interval.

Six studies presented separately the proportions of consistent condom use with regular and casual sexual partners during anal intercourse. The effect sizes in the meta-analysis were similar with regular sexual partners (mean ES, 0.41; 95% CI, 0.18--0.63), and with casual sexual partners (mean ES, 0.52; 95% CI, 0.24--0.79; [Figure 3](#pone-0072747-g003){ref-type="fig"}).

![Forest plot of effect size: the impact of behavioral interventions on consistent condom use during anal intercourses among MSM in China by types of sexual partners.](pone.0072747.g003){#pone-0072747-g003}

Uptake of HIV Testing {#s2c}
---------------------

Of ten studies evaluating uptake of HIV testing eight reported an increased proportion of taking HIV testing while two did not [@pone.0072747-Lau1], [@pone.0072747-Xu2]. Meta-analysis of ten studies showed a marked increase in taking HIV testing post intervention (mean ES, 0.55; 95% CI, 0.38--0.71; *P*\<0.01). Substantial heterogeneity was found across these six studies (I^2^ = 83.8%, *P*\<0.01; [Figure 4](#pone-0072747-g004){ref-type="fig"}).

![Forest plot of effect size: the impact of behavioral interventions on uptake of HIV testing among MSM in China.](pone.0072747.g004){#pone-0072747-g004}

HIV/AIDS-related Knowledge and Attitudes {#s2d}
----------------------------------------

Of 21 studies reported HIV/AIDS knowledge outcome, 20 showed statistically significant increase, while 4 reported no statistically different change [@pone.0072747-Wang3], [@pone.0072747-Wang4], [@pone.0072747-Ding1], [@pone.0072747-Li1] ([Figure 5](#pone-0072747-g005){ref-type="fig"}). Meta-analysis found a significant positive effect size (mean ES, 0.77; 95% CI, 0.60--0.94; *P*\<0.01). Large statistical heterogeneity was observed (I^2^ = 90.2%; *P*\<0.01).

![Forest plot of effect size: the impact of behavioral interventions on HIV/AIDS-related knowledge and attitude among MSM in China.](pone.0072747.g005){#pone-0072747-g005}

Only three studies evaluated AIDS-related attitudes [@pone.0072747-Gao1], [@pone.0072747-Wang2], [@pone.0072747-Gao2], and all found improvement of AIDS-related attitudes. The summary ES was 1.35 (95% CI, 0.91, 1.79; *P*\<0.01), but large heterogeneity was noted (I^2^ = 63.6%, *P* = 0.04).

HIV and Syphilis Infections {#s2e}
---------------------------

Ten serial cross-sectional studies assessed HIV/STI outcomes. Six studies had no summary effect on syphilis prevalence (mean ES, −0.01; 95% CI, −0.19, 0.17; *P* = 0.93), and ten studies had a positive overall effect on increasing HIV prevalence (mean ES, 0.23; 95% CI, 0.02, 0.45; *P* = 0.03). Large statistical heterogeneity was observed for two outcomes ([Figure 6](#pone-0072747-g006){ref-type="fig"}).

![Forest plot of effect size: the impact of behavioral interventions on HIV and syphilis prevalence among MSM in China.](pone.0072747.g006){#pone-0072747-g006}

Discussion {#s3}
==========

Our systematic review and meta-analysis evaluate the effectiveness of behavioral interventions on the HIV-related behaviors, knowledge and attitudes, as well as prevalence of HIV/STI among MSM in China. Compared to two previous meta-analytic reviews involving 16 [@pone.0072747-Huang1] and 22 [@pone.0072747-Zheng1] individual studies in China, respectively, our review included 34 studies with four intervention study designs. Our meta-analysis confirmed previous reviews on increasing consistent condom use, HIV/AIDS knowledge [@pone.0072747-Zheng1], and uptake of HIV testing [@pone.0072747-Huang1], [@pone.0072747-Zheng1]. Our review also evaluated the effect on HIV and syphilis prevalence, but showed no positive effect.

Consistent condom use is seen as the most relevant HIV-related behavior to evaluate effectiveness of interventions among MSM. Our meta-analysis found that a variety of behavioral interventions conducted in China were associated with a significant increase in consistent condom use in anal intercourse. The positive effect was consistent in different study designs and by different measurement periods. However, HIV prevalence among MSM in China increased from 0.6% in 2003 to 7.4% in 2009 from a systematic review and meta-analysis [@pone.0072747-Meng1]. The possible reasons for this contradiction might be: i) consistent condom use is a poor surrogate index of HIV risk because social desirability bias exists among MSM with consequent over-reporting of condom use; ii) prevention and control measures are not tailored to the needs and context of MSM communities, overestimating their effectiveness; iii) positive reports of program effectiveness might be easier to publish in peer-reviewed journals, resulting in a positive publication bias.

Unprotected anal intercourse (UAI) with casual sexual partners is known as an important route of HIV acquisition for MSM. Recent research has indicated that higher levels of UAI may be associated with one's level of perceived familiarity with casual sexual partners [@pone.0072747-vandenBoom1]. Likewise, UAI with regular sexual partners has increasingly attracted attention in recent years [@pone.0072747-Slavin1], [@pone.0072747-Blais1]. It is notable that behavioral interventions significantly increased consistent condom use during anal intercourse both with casual (41% increase) and regular sexual partners (52% increase) in our subgroup meta-analyses, involving 12 individual studies. Our stratified analyses by number of study sites, venue of recruiting participants, type of risk reduction interventions, sample size at baseline, and rigor score of study design also found significant increases of consistent condom use during anal sex in these specific subgroups. The evidence base currently provides general support for intervention approaches, and the efforts to better understand mechanisms of intervention effects and confirm positive effects in high rigor designs should be prioritized.

Client-initiated HIV testing and counseling, known as voluntary counseling and testing (VCT), and provider-initiated HIV testing and counseling in health facilities have helped millions of people learn their HIV status, but global coverage of HIV testing and counseling programs remains low, especially in China. Low levels of HIV prevalence and high levels of stigma and discrimination against people living with HIV/AIDS are disincentives for VCT [@pone.0072747-World1], [@pone.0072747-International1]. Many studies have confirmed intervention effects of VCT promotion [@pone.0072747-Vidanapathirana1], [@pone.0072747-Davis1], [@pone.0072747-Sweat1], but this significant effect may wane over time since the intervention [@pone.0072747-Vidanapathirana1]. Eight of ten studies from China reported positive effects on seeking HIV testing, continuing 6- to 48-months after intervention. In our meta-analysis, a 55% increase in HIV test seeking was associated with the behavioral interventions, though one study from Hong Kong showed 29% decrease at 6 months after internet-based intervention [@pone.0072747-Lau1]. Far more work is needed in China to identify the effectiveness of different interventions on various outcomes over time.

Correct HIV-related knowledge and positive attitudes toward HIV/AIDS have been used to evaluate the interventions among MSM, especially in China. Inconsistent scales for quantitative measurement of HIV-related knowledge and attitudes present substantial challenges for estimating overall effectiveness. Combining the individual studies using meta-analysis suggested a 77% increase of HIV-related knowledge involving 21 Chinese studies, and a 135% increase of HIV-related positive attitudes in three Chinese studies [@pone.0072747-Gao1], [@pone.0072747-Wang2], [@pone.0072747-Gao2].

It is challenging and costly to measure incidence of HIV or other STD, particularly over a meaningful and substantial time period. To our knowledge, only one meta-analysis among two studies has been done and shown 80% reduction of STI acquisition (chlamydia or gonorrhea) among people living with HIV/AIDS [@pone.0072747-Wingood1], [@pone.0072747-Wolitski1], [@pone.0072747-Crepaz1]. Our study failed to observe reduction of HIV and syphilis infections among Chinese MSM by synthesizing the findings from ten serial cross-sectional studies that measured one or both infections, though various behavioral interventions were performed in some selected cities, though a 40% increase of consistent condom use was observed in the subgroup analysis of serial cross-sectional studies. The similar finding from a recent meta-analytic review showed that HIV prevalence among MSM has substantially increased from 2001--2009 across all Chinese regions [@pone.0072747-Chow1]. More comprehensive behavioral and biomedical interventions are needed to control this ongoing disaster.

Strengths and Limitations {#s4}
=========================

The strength of our study is our thoroughness and methodological rigor of the meta-analysis for risk reduction interventions among Chinese MSM. Our elucidation of the impact of behavioral interventions on behavior and knowledge is useful in identifying ongoing research and service needs. Our analyses adjusted baseline data between study arms in evaluating the effect of interventions and combined continuous and categorical outcomes of targeted outcomes, something done rarely in other reviews.

Our meta-analysis has limitations as well. All studies used self-reported behaviors, knowledge and attitudes as the outcomes of interest, which might be subject to social desirability bias. Second, no comparison group was included in pre-and-post studies and non-randomization designs represented most of the included studies, contributing a large portion of heterogeneity and reducing the power of analysis. Third, major publication bias in the formal evaluations was found. Positive outcomes might be easier to be accepted by journals. Finally, although 12 databases were searched for the reviews and extensive check for completeness by cross-referencing were employed, we cannot exclude having missed a relevant study.

Methods {#s5}
=======

Literature Search and Study Selection {#s5a}
-------------------------------------

A literature search was conducted to identify studies evaluating the effectiveness of HIV risk reduction interventions among MSM in China. Twelve electronic databases were searched for publications in peer-reviewed journals through May 2013, including AMED (Allied and Complementary Medicine Database, Ovid Technologies, Inc., New York), British Nursing Index (Ovid Technologies, Inc., New York), CNKI (Tongfang Knowledge Network Technology Co., Ltd., Beijing, China), CQVIP (Chongqing VIP Information Co., Ltd., Chongqing, China), EMBASE (Elsevier, Amsterdam, The Netherlands), EconLit (The American Economic Association, New York), ERIC (Education Resources Information Centre, Institute of Education Sciences of the U.S. Department of Education, Washington), Ovid Medline (Ovid Technologies, Inc., New York), PsycINFO (American Psychological Association, Washington), Scopus (Elsevier, Amsterdam, The Netherlands), Wanfang Data (Chinese Ministry of Science & Technology, Beijing, China), and Web of Science (Thomson Scientific Technical Support, New York). The following combination of key words was used in literature search: (men who have sex with men OR MSM OR homosexual men OR gay men OR bisexual men OR transgender women OR money boy) AND (HIV OR AIDS OR sexually transmitted infections OR sexually transmitted diseases) AND (intervention OR randomized clinical trial OR treatment OR prevention OR adherence OR compliance). All publications were exported to an Endnote file (Endnote X4, Thomson Reuters, San Francisco, CA), and duplicates were deleted. The title and abstract of each paper were independently reviewed by two authors (Liu Y, and Dahiya K) to determine its relevance to the topic. Then, full texts were reviewed whether the paper assessed impacts of risk reduction intervention on HIV-related outcomes among MSM in China. Cross-referencing by checking the cited references in the included papers was also performed as an additional tool to identify relevant publications.

Inclusion Criteria {#s5b}
------------------

Studies that met the following criteria were included in this meta-analysis: 1) studies evaluating the effectiveness of HIV risk reduction interventions among MSM, including randomized clinical trials (RCTs), quasi-experimental studies, pre-and-post intervention studies without control groups, and serial cross-sectional intervention studies; 2) studies conducted in China; 3) studies reporting HIV-related knowledge, attitudes and behaviors, as well as prevalence of HIV or other sexually transmitted infections (STIs); 4) published in English or Chinese. Duplication of human samples of included studies was evaluated by two authors and these samples were only used once in our analyses.

Data Extraction {#s5c}
---------------

Data extraction was independently done by two authors (Liu Y, and Dahiya K) using a standardized form including items on lead author, publication year, study city, venue of recruiting participants, study design, demographic characteristics of study groups, characteristics of sex partners (regular or casual), description of intervention and comparison, duration of follow-up, drop-out rate, proportion or mean frequency of HIV-related outcomes at different follow-up time points, and rigor score of study design. Any disagreements between two data extractors were discussed with the team until a consensus was reached.

Rigor Score {#s5d}
-----------

The rigor of study design for each study was assessed using an 8-item scale, as used in other reviews [@pone.0072747-Medley1], [@pone.0072747-Kennedy1] plus an additional item of sample size with a cut-off value of \>100 representing good statistical power. The scale is additive, with 1 point for each item. Therefore, the rigor score ranges from 0 to 9, with a higher value representing better study design.

Statistical Methods {#s5e}
-------------------

We focused on six main outcomes in our meta-analysis: (1) consistent condom use, (2) uptake of HIV testing, (3) HIV-related knowledge, (4) HIV-related attitudes, (5) HIV infection, and (6) syphilis infection. For studies with multiple intervention arms [@pone.0072747-Gao1], the effect sizes were calculated using the same comparison arm. When some studies had multiple measurements at different follow-up time points, the last follow-up assessment was used in the meta-analysis for estimating the overall effect size. When such outcome variables were not explicitly reported, they were derived from data provided in the paper or were secured from the authors when possible.

Effect size was calculated on the basis of targeted outcomes from the baseline and latest follow-up assessments between study arms (or self-pre-and-post intervention studies without control arms, or serial cross-sectional intervention studies). Standard mean differences (SMDs) and 95% confidence intervals (Cls) were used to estimate the effectiveness of risk reduction interventions. When studies reported dichotomous outcomes, we transformed odds ratios into SMDs using Cox transformation [@pone.0072747-Cox1], [@pone.0072747-SanchezMeca1]. SMD in each study arm was calculated as a fraction of dividing the difference of two means at follow-up and baseline by the pooled standard deviation (SD) of these two means [@pone.0072747-Becker1]. The difference of SMDs from the intervention and comparison arms was used for meta-analysis. As the study arms might not be comparable at baseline, even in RCTs, we used Becker's strategy to adjust for the reported difference between arms at baseline when calculating SMDs; for pre-and-post intervention studies without a comparison arm and for serial cross-sectional intervention studies, we assumed the value for the comparison arm was zero [@pone.0072747-Becker1]. An SMD difference\>0 indicated an increase in the given outcome in the intervention group relative to the control group. Random effects models were derived using the DerSimonian-Laird method [@pone.0072747-DerSimonian1], [@pone.0072747-Lipsey1] to establish overall effect sizes. Random effects estimates allowed for variation of true effects across studies [@pone.0072747-Normand1].

We assessed heterogeneities by I^2^ statistics [@pone.0072747-Deeks1], and identified outliers by standardized deleted residuals analyses. The funnel plot, Begg and Mazumdar rank correlation test, and Egger's test of the intercept were employed to assess publication bias [@pone.0072747-Rothstein1].

We conducted pre-planned subgroup analyses to examine consistent condom use during anal intercourse by type of sexual partners (regular vs. casual), length of recall period on consistent condom use (last sex vs. last 6 months), number of study site (one vs. multiple cities), venue of recruiting participants (establishment-based vs. other), type of risk reduction interventions (peer-led vs. other), study design (randomized clinical trial evaluation vs. quasi-experimental evaluation vs. self-pre-and-post intervention evaluation without control groups vs. serial cross-sectional intervention evaluation), sample size at baseline (≤300 vs. \>300), and rigor score (1 vs. \>1). We conducted sensitivity analyses to determine the stability of intervention effects by evaluating whether the overall effect size was sensitive to inclusion of each individual study. The R/S plus software version 2.15.1 was used for the meta-analyses [@pone.0072747-RS1].

Conclusions {#s6}
===========

Our analysis suggested that available behavioral interventions can increase consistent condom use during anal sex, regardless of type of sexual partners, encourage successfully seeking of HIV testing, increase HIV-related knowledge and improve attitudes. But these interventions have had limited impacts on HIV or syphilis infection per se. Well-designed intervention studies are needed to explore the effectiveness of a variety of MSM-focused behavioral intervention programs in China.
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